President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower prices paid in other countries, what’s called most-favored-nation pricing. If drug companies do not lower their prices accordingly, the order proposes other strategies, such as importing drugs from other countries. The post Trump Strategy to Rein In…
Experts agree that the incoming Trump administration will likely shake things up in the prescription drug world — most notably when it comes to research and development, drug pricing and PBM reform. The post What Might the Future of Prescription Drugs Look Like Under Trump? appeared first on MedCity News.
Whether pursuing high-tech solutions, tapping into natural elements, or doubling down on smaller building sizes, the future of healthcare facilities design boils down to improving patient access and nurturing employee retention. The post Facilities Built for the Future: 3 Healthcare Design Trends Emerging in 2025 and Beyond appeared first on MedCity News.
At JPM25, Nvidia announced four new partnerships focused on scaling AI models across the healthcare industry. The company is teaming up with Mayo Clinic, Illumina, IQVIA and Arc Institute. The post Nvidia Announces Partnerships with Mayo Clinic, Illumina & More at JPM25 appeared first on MedCity News.
Recently signed SB 660 reinforces accountability and participation in DxF
UnitedHealth Group executives also say the measure forbidding simultaneous ownership of pharmacies and PBMs will hurt patients’ access to medicines. Both companies said they will work with lawmakers on possible solutions.
Bristol Myers Squibb is paying $50 million to begin a collaboration with Janux Therapeutics, a company that develops T cell engagers that activate specifically at the site of the tumor. It’s the second big pharma alliance for Janux, which has been working with Merck. The post BMS Tries Again With T Cell Engagers, Turning to…
All healthcare entities storing or transferring patient health information needs to be aware of a proposed update to HIPAA tackling data encryption. Bryan Marlatt, chief regional officer at CyXcel The post Pivot: Discussing the Impact of a Proposed HIPAA Security Update appeared first on MedCity News.
Antibiotic resistance is a growing global threat with serious health and economic consequences. Yet there is progress – from rapid PCR diagnostics and AI-driven research to new drug development and innovative funding models. The post Innovations Offer Hope in the Fight Against Antibiotic Resistance appeared first on MedCity News.
It’s not the flashiest technologies or rapid-speed AI breakthroughs that can do it. It’s the technologies laser-focused on the unglamorous but all-consuming coordination problems that suck up medical staff’s time, stress them out, and compromise patient care. The post Innovation Fatigue is Rampant: What’s the Rx to Fix It? appeared first on MedCity News.